Healthcare
Centene Corporation(CNC)
Live Price
Offline$63.68
+4.36% today
1Y Change
+18.00%
Window
Jun 25, 2025 β Jun 23, 2026
- Market Cap
- $26.15B
- Revenue Growth
- +19.4%
- EPS Growth
- -313.7%
- Dividend Yield
- 0.0%
Coverage: 249 bars Β· Jun 25, 2025 β Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Centene Corporation (CNC) is a Healthcare stock with a market cap of $26.15B and listed on NYSE. The stock last traded around $63.68 and up 18.0% across the available one-year price window (Jun 25, 2025 β Jun 23, 2026). Baseline metrics include revenue growth of +19.4%, EPS growth of -313.7%, a dividend yield of 0.0%. What stands out right now is revenue +19.4%, EPS -313.7%, free cash flow +981.8% with operating margin -0.2% and ROIC -17.7%. Valuation is more restrained than many high-expectation growth names at price/sales 0.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines CNC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+19.4% vs +7.6% peer median
Operating Margin
Below sector median
-0.2% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report landed above expectations
Q2 2026 was reported on May 29, 2026 with an EPS surprise of +24.3%.
The operating picture looks softer than before
Revenue is at +19.4% and EPS is at -313.7%, with operating margin around -0.2%.
The next real check-in already has a date
The next earnings event is scheduled for Jun 25, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -2.9% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS Ξ | 1D | 5D | 20D |
|---|---|---|---|---|
Q2 2026 May 29, 2026 | +24.3% | +4.0% | +4.6% | β |
Q2 2026 Apr 28, 2026 | +58.2% | +8.9% | +6.9% | +18.7% |
Q1 2026 Mar 4, 2026 | +150.0% | -3.8% | -20.3% | -24.5% |
Benchmark Edge
CNC vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CNC
β
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CNC Max Drawdown
-55.50%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CNC and SPY.
Company Overview
Centene Corp
NYSE
Centene Corporation is a leading American for-profit healthcare enterprise specializing in managed care services, primarily serving government-sponsored programs like Medicaid, Medicare, and the Health Insurance Marketplace. Headquartered in the Greater St. Louis area, it acts as an intermediary for both government-subsidized and privately insured healthcare, delivering affordable, high-quality coverage to nearly 28 million members across all 50 statesβone in every 15 individuals nationwide. Founded in 1984 as a nonprofit Medicaid plan in Wisconsin by Elizabeth Brinn, the company evolved through strategic acquisitions, going public in 2001 and expanding under leaders like Michael Neidorff and current CEO Sarah London since 2022. Its core segments include Medicaid with local plans like Arizona Complete Health and Sunshine Health, commercial products for employer groups and individuals, and specialty services in behavioral health and pharmacy benefits. Ranked among the Fortune 500's top companies by revenue, Centene emphasizes a localized approach with culturally sensitive care, data-driven management, and innovation to address underserved populations, enhancing health equity and community wellness.
- Leadership
- Ms. Sarah M. London
- Employees
- 61.0k
- Street Address
- Centene Plaza, 7700 Forsyth Boulevard
- Mailing
- Saint Louis, MO, 63105
- Region
- Saint Louis, MO, United States
- Last Updated
- May 8, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- β
- EV/EBITDA
- β
- Price/Sales
- 0.1
- Price/Book
- 1.2
Growth
- Revenue
- +19.4%
- EPS
- -313.7%
- Free Cash Flow
- +981.8%
Profitability
- Gross Margin
- 7.1%
- Operating Margin
- -0.2%
- Net Margin
- -3.4%
- ROE
- -28.7%
- ROIC
- -17.7%
Balance Sheet
- Debt/Equity
- 0.76
- Current Ratio
- 1.12
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.